Arcadia Biosciences, Inc.
US ˙ NasdaqCM ˙ US0390143032

Introduction

This page provides a comprehensive analysis of the known insider trading history of Peter V Sperling. Insiders are officers, directors, or significant investors in a company. It is illegal for insiders to make trades in their companies based on specific, non-public information. This does not mean it is illegal for them to make any trades in their own companies. However, they must report all trades to the SEC via a Form 4. Despite these restrictions, academic research suggests that insiders - in general - tend to outperform the market in their own companies.

Average Trade Profitability

The average trade profitability is the average return of all the open market purchases made by the insider in the last three years. To calculate this, we examine every open-market, unplanned purchase made by the insider, excluding all trades that were marked as part of a 10b5-1 trading plan. We then calculate the average performance of those trades over 3, 6, and 12 months, averaging each of those durations to generate a final performance metric for each trade. Finally, we average all of the performance metrics to calculate a performance metric for the insider. This list only includes insiders that have made at least three trades in the last two years.

If this insiders trade profitability is "N/A", then the insider either has not made any open-market purchases in the last three years, or the trades they’ve made are too recent to calculate a reliable performance metric.

Update Frequency: Daily

See the list of most profitable insider traders.

Companies with Reported Insider Positions

The SEC filings indicate Peter V Sperling has reported holdings or trades in the following companies:

Security Title Latest Reported Holdings
US:APOL / Apollo Education Group, Inc. Chairman of the Board, Director 0
US:RKDA / Arcadia Biosciences, Inc. 10% Owner 0
How to Interpret the Charts

The following charts show the stock performance of securities subsequent to each open-market, non-planned trade made by Peter V Sperling. Non-planned trade are trades that were not made as part of a 10b5-1 trading plan. The stock performance is charted as cumulative percent change in share price. For example, if an insider trade was made on January 1, 2019, the chart will show the daily percent change of the security to the present day. If the share price were to go from $10 to $15 during this time, the cumulative percent change in share price would be 50%. A change in price from $10 to $20 would be 100%, and a change in price of $10 to $5 would be -50%.

Ultimately, we are trying to determine how closely the insider’s trades correlate to excess returns (positive or negative) in the share price in order to see if the insider is timing their trades to profit from insider information. Consider the situation where an insider was doing this. In this situation, we would expect either (a) positive returns after purchases, or (b) negative returns after sales. In the case of (a), the PURCHASE chart would show a series of upwardly sloping curves, indicating positive returns after each purchase transaction. In the case of (b), the SALE chart would show a series of downward sloping curves, indicating negative returns after each sale transaction.

However, this alone is not enough to draw conclusions. If, for example, the share price of the company was in a non-cyclical climb over many years, then we would expect all the post-purchase plots to be upwardly sloping. Likewise, non-cyclical declines over many years would result in downward sloping post-trade plots. Neither of these charts would suggest insider trading activity.

The strongest indicator would be a situation where the share price was extremely cyclical, and there were both positive signals in the PURCHASE chart and negative plots on the SALE chart. This situation would be highly suggestive of an insider that was timing trades to their financial advantage.

Insider Purchases RKDA / Arcadia Biosciences, Inc. - Short Term Profit Analysis

In this section, we analyze the profitability of every unplanned, open-market insider purchase made in RKDA / Arcadia Biosciences, Inc.. This analysis helps to understand if the insider consistently generates abnormal returns, and is worth following. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market purchases that were not part of an automatic trading plan.

Trade Date Ticker Insider Reported
Shares
Reported
Price
Adjusted
Shares
Adjusted
Price
Cost Basis Days to
Max
Price at
Max
Max
Profit ($)
Max Return (%)
2015-05-20 RKDA BISHOP TERRI C 1,000,000 8.0000 33,333 240.0000 8,000,000 23 6984 224,797,672 2,809.97

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

RKDA / Arcadia Biosciences, Inc. Insider Trades
Insider Sales RKDA / Arcadia Biosciences, Inc. - Short Term Loss Analysis

In this section, we analyze the short-term loss avoidance of every unplanned, open-market insider sale made in RKDA / Arcadia Biosciences, Inc.. A consistent pattern of loss avoidance may suggest that future sale transactions may predict declines in price. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market sales that were not part of an automatic trading plan.

Trade Date Ticker Insider Reported
Shares
Reported
Price
Adjusted
Shares
Adjusted
Price
Cost Basis Days to
Min
Price at
Min
Max Loss
Avoided ($)
Max Loss
Avoided (%)
There are no known unplanned open-market trades for this insider and security combination

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

RKDA / Arcadia Biosciences, Inc. Insider Trades
Insider Trading History

This table shows the complete list of insider trades made by Peter V Sperling as disclosed to the Securities Exchange Commission (SEC).

File Date Tran Date Form Ticker Security Code 10b5-1 Shares Remaining Shares Percent
Change
Share
Price
Tran
Value
Remaining
Value
2017-02-02 2017-02-01 4 APOL APOLLO EDUCATION GROUP INC
Non-Qualified Stock Option (right to buy)
D - Sale to Issuer -42,200 0 -100.00
2017-02-02 2017-02-01 4 APOL APOLLO EDUCATION GROUP INC
Non-Qualified Stock Option (right to buy)
D - Sale to Issuer -18,020 0 -100.00
2017-02-02 2017-02-01 4 APOL APOLLO EDUCATION GROUP INC
Non-Qualified Stock Option (right to buy)
D - Sale to Issuer -20,664 0 -100.00
2017-02-02 2017-02-01 4 APOL APOLLO EDUCATION GROUP INC
Non-Qualified Stock Option (right to buy)
D - Sale to Issuer -2,472 0 -100.00
2017-02-02 2017-02-01 4 APOL APOLLO EDUCATION GROUP INC
Non-Qualified Stock Option (right to buy)
D - Sale to Issuer -8,000 0 -100.00
2017-02-02 2017-02-01 4 APOL APOLLO EDUCATION GROUP INC
Non-Qualified Stock Option (right to buy)
D - Sale to Issuer -8,000 0 -100.00
2017-02-02 2017-02-01 4 APOL APOLLO EDUCATION GROUP INC
Class B Common Stock
D - Sale to Issuer -232,067 0 -100.00 10.00 -2,320,670
2017-02-02 2017-02-01 4 APOL APOLLO EDUCATION GROUP INC
Class B Common Stock
D - Sale to Issuer -1 0 -100.00 10.00 -10
2017-02-02 2017-02-01 4 APOL APOLLO EDUCATION GROUP INC
Class A Common Stock
D - Sale to Issuer -800,000 0 -100.00 10.00 -8,000,000
2017-02-02 2017-02-01 4 APOL APOLLO EDUCATION GROUP INC
Class A Common Stock
D - Sale to Issuer -86,787 0 -100.00 10.00 -867,870
2016-08-16 2016-08-13 4 APOL APOLLO EDUCATION GROUP INC
Class A Common Stock
F - Taxes -2,530 86,787 -2.83 9.04 -22,871 784,554
2016-08-16 2016-08-12 4 APOL APOLLO EDUCATION GROUP INC
Class A Common Stock
F - Taxes -1,986 89,317 -2.18 9.04 -17,953 807,426
2016-07-06 2016-07-02 4 APOL APOLLO EDUCATION GROUP INC
Class A Common Stock
F - Taxes -1,771 91,303 -1.90 9.10 -16,116 830,857
2015-10-28 2015-10-26 4 APOL APOLLO EDUCATION GROUP INC
Class A Common Stock
S - Sale -551,156 0 -100.00 7.15 -3,938,175
2015-10-28 2015-10-26 4 APOL APOLLO EDUCATION GROUP INC
Class A Common Stock
S - Sale -1,262,799 92,874 -93.15 7.15 -9,023,078 663,613
2015-10-28 2015-10-23 4 APOL APOLLO EDUCATION GROUP INC
Class A Common Stock
S - Sale -1,379,239 1,355,673 -50.43 7.28 -10,042,653 9,871,062
2015-10-26 2015-10-22 4 APOL APOLLO EDUCATION GROUP INC
Class A Common Stock
F - Taxes -1,986 2,735,112 -0.07 7.18 -14,269 19,651,780
2015-08-14 2015-08-13 4 APOL APOLLO EDUCATION GROUP INC
Class A Common Stock
F - Taxes -2,530 2,737,098 -0.09 12.04 -30,461 32,954,660
2015-08-14 2015-08-12 4 APOL APOLLO EDUCATION GROUP INC
Non-Qualified Stock Option (right to buy)
A - Award 42,200 42,200
2015-08-14 2015-08-12 4 APOL APOLLO EDUCATION GROUP INC
Class A Common Stock
A - Award 47,544 2,739,628 1.77
2015-07-08 2015-07-06 4 APOL APOLLO EDUCATION GROUP INC
Class A Common Stock
F - Taxes -529 2,692,084 -0.02 13.04 -6,898 35,104,775
2015-07-07 2015-07-02 4 APOL APOLLO EDUCATION GROUP INC
Class A Common Stock
F - Taxes -1,771 2,692,613 -0.07 12.93 -22,899 34,815,486
2015-05-21 2015-05-20 4 RKDA Arcadia Biosciences, Inc.
Series C Convertible Preferred Stock
C - Conversion -9,345,794 0 -100.00
2015-05-21 2015-05-20 4 RKDA Arcadia Biosciences, Inc.
Series C Convertible Preferred Stock
C - Conversion -9,345,794 0 -100.00
2015-05-21 2015-05-20 4 RKDA Arcadia Biosciences, Inc.
Series B Convertible Preferred Stock
C - Conversion -15,391,006 0 -100.00
2015-05-21 2015-05-20 4 RKDA Arcadia Biosciences, Inc.
Series B Convertible Preferred Stock
C - Conversion -15,391,006 0 -100.00
2015-05-21 2015-05-20 4 RKDA Arcadia Biosciences, Inc.
Series A Convertible Preferred Stock
C - Conversion -60,681,805 0 -100.00
2015-05-21 2015-05-20 4 RKDA Arcadia Biosciences, Inc.
Series A Convertible Preferred Stock
C - Conversion -60,681,805 0 -100.00
2015-05-21 2015-05-20 4 RKDA Arcadia Biosciences, Inc.
Common Stock
C - Conversion 2,336,448 22,515,364 11.58
2015-05-21 2015-05-20 4 RKDA Arcadia Biosciences, Inc.
Common Stock
C - Conversion 3,847,751 20,178,916 23.56
2015-05-21 2015-05-20 4 RKDA Arcadia Biosciences, Inc.
Common Stock
C - Conversion 15,170,451 16,331,165 1,306.99
2015-05-21 2015-05-20 4 RKDA Arcadia Biosciences, Inc.
Common Stock
P - Purchase 1,000,000 1,160,714 622.22 8.00 8,000,000 9,285,712
2015-05-14 3 RKDA Arcadia Biosciences, Inc.
Common Stock
321,428
2015-05-14 3 RKDA Arcadia Biosciences, Inc.
Common Stock
321,428
2015-05-14 3 RKDA Arcadia Biosciences, Inc.
Common Stock
321,428
2015-05-14 3 RKDA Arcadia Biosciences, Inc.
Common Stock
321,428
2015-05-14 3 RKDA Arcadia Biosciences, Inc.
Common Stock
321,428
2015-05-14 3 RKDA Arcadia Biosciences, Inc.
Common Stock
321,428
2015-05-14 3 RKDA Arcadia Biosciences, Inc.
Common Stock
321,428
2014-10-17 2014-10-15 4 APOL APOLLO EDUCATION GROUP INC
Class A Common Stock
F - Taxes -2,184 2,694,384 -0.08 24.73 -54,010 66,632,116
2014-08-14 2014-08-12 4 APOL APOLLO EDUCATION GROUP INC
Non-Qualified Stock Option (right to buy)
A - Award 18,020 18,020
2014-08-14 2014-08-12 4 APOL APOLLO EDUCATION GROUP INC
Class A Common Stock
A - Award 21,132 2,696,568 0.79
2014-07-07 2014-07-06 4 APOL APOLLO EDUCATION GROUP INC
Class A Common Stock
F - Taxes -724 2,675,436 -0.03 32.02 -23,182 85,667,461
2014-07-07 2014-07-02 4 APOL APOLLO EDUCATION GROUP INC
Class A Common Stock
F - Taxes -1,529 2,676,160 -0.06 30.82 -47,124 82,479,251
2013-11-07 2013-10-28 4 APOL APOLLO GROUP INC
Class A Common Stock
S - Sale -100,000 800,000 -11.11 27.83 -2,782,700 22,261,600
2013-10-18 2013-10-17 4 APOL APOLLO GROUP INC
Class A Common Stock
F - Taxes -1,529 2,677,689 -0.06 21.10 -32,262 56,499,238
2013-08-15 2013-08-13 4 APOL APOLLO GROUP INC
Non-Qualified Stock Option (right to buy)
A - Award 20,664 20,664
2013-08-15 2013-08-13 4 APOL APOLLO GROUP INC
Class A Common Stock
A - Award 26,920 2,679,218 1.01
2013-07-09 2013-07-06 4 APOL APOLLO GROUP INC
Class A Common Stock
F - Taxes -724 2,652,298 -0.03 17.94 -12,989 47,582,226
2013-07-05 2013-07-02 4 APOL APOLLO GROUP INC
Class A Common Stock
F - Taxes -198 2,653,022 -0.01 18.08 -3,580 47,966,638
2013-05-02 2013-05-01 4 APOL APOLLO GROUP INC
Class A Common Stock
A - Award 10,512 2,653,220 0.40 17.70 186,062 46,961,994
2012-10-23 2012-10-19 4 APOL APOLLO GROUP INC
Class A Common Stock
F - Taxes -444 2,642,708 -0.02 20.39 -9,053 53,884,816
2012-07-10 2012-07-06 4 APOL APOLLO GROUP INC
Class A Common Stock
F - Taxes -294 2,643,152 -0.01 36.55 -10,746 96,607,206
2012-07-05 2012-07-02 4 APOL APOLLO GROUP INC
Class A Common Stock
A - Award 705 2,643,446 0.03
2012-07-05 2012-07-02 4 APOL APOLLO GROUP INC
Class A Common Stock
A - Award 8,324 2,643,446 0.32
2012-07-05 2012-07-02 4 APOL APOLLO GROUP INC
Class A Common Stock
F - Taxes -218 2,635,122 -0.01 36.34 -7,922 95,760,333
2012-03-05 2012-03-01 4 APOL APOLLO GROUP INC
Class A Common Stock
S - Sale X -10,000 2,635,340 -0.38 42.33 -423,273 111,546,827
2012-02-02 2012-02-01 4 APOL APOLLO GROUP INC
Class A Common Stock
S - Sale X -30,000 2,645,340 -1.12 52.87 -1,586,229 139,870,501
2012-01-18 2012-01-13 4 APOL APOLLO GROUP INC
Class A Common Stock
S - Sale -25,000 2,675,340 -0.93 58.04 -1,451,080 155,285,295
2012-01-17 2012-01-13 4 APOL APOLLO GROUP INC
Class A Common Stock
S - Sale -75,000 2,700,340 -2.70 57.10 -4,282,635 154,194,275
2012-01-17 2012-01-12 4 APOL APOLLO GROUP INC
Class A Common Stock
S - Sale -50,000 2,775,340 -1.77 57.10 -2,855,155 158,480,518
2012-01-05 2012-01-03 4 APOL APOLLO GROUP INC
Class A Common Stock
S - Sale X -1,729 2,825,340 -0.06 54.16 -93,642 153,019,849
2012-01-05 2012-01-03 4 APOL APOLLO GROUP INC
Class A Common Stock
S - Sale X -28,271 2,827,069 -0.99 53.32 -1,507,390 150,737,340
2011-12-05 2011-12-01 4 APOL APOLLO GROUP INC
Class A Common Stock
S - Sale X -3,031 2,928,573 -0.10 48.69 -147,574 142,586,948
2011-12-05 2011-12-01 4 APOL APOLLO GROUP INC
Class A Common Stock
S - Sale X -6,969 2,931,604 -0.24 48.17 -335,667 141,203,052
2009-04-28 2009-04-24 4 APOL APOLLO GROUP INC
Forward Sale Contract (obligation to sell)
J - Other -500,000 0 -100.00
2009-04-28 2009-04-24 4 APOL APOLLO GROUP INC
Class A Common Stock
J - Other -436,500 5,749,916 -7.06
2007-09-19 2007-08-31 4 APOL APOLLO GROUP INC
Class A Common Stock
F - Taxes -1,126 11,191,107 -0.01 58.67 -66,062 656,582,248
P
Open market or private purchase of non-derivative or derivative security
S
Open market or private sale of non-derivative or derivative security
A
Grant, award, or other acquisition of securities from the company (such as an option)
C
Conversion of derivative
D
Sale or transfer of securities back to the company
F
Payment of exercise price or tax liability using portion of securities received from the company
G
Gift of securities by or to the insider
K
Equity swaps and similar hedging transactions
M
Exercise or conversion of derivative security received from the company (such as an option)
V
A transaction voluntarily reported on Form 4
J
Other (accompanied by a footnote describing the transaction)